DR Ryan- Agreed... Opioids are not getting approved unless it is something really innovative where benefits strongly outweigh risks. Intelli drug was not even close to approval. For investors in competitors, please listen to Intelli ADCOM. Certainly this ADCOM was not good news for you guys. And celebration of this denial will be shortly lived as your companies products will likely see similar fates in the future. Intelli even showed no food effect. The panel did not even care about this. But it was reason enough to deny other drugs in the past...